Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -701.55% is 123% below its 5-year average of -314.24%, near the high end of its 5-year range (-5360.54%–-9.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.09% above its 12-month average of -1715.00%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -701.55%.
RETURN ON INVESTED CAPITAL (ROIC)
-701.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1715.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-499.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-314.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.09%
CURRENT VS 3Y AVG
-40.32%
CURRENT VS 5Y AVG
-123.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-1867.33%
vs the sector median at left
Greenwich LifeSciences, Inc.
Market Cap
$231.77M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-1715.00%
3Y Avg
-499.97%
5Y Avg
-314.24%
Market Cap
$231.37M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-43.46%
3Y Avg
-51.45%
5Y Avg
-53.92%
Market Cap
$232.72M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$235.08M
Return on Invested Capital (ROIC)
6.83%
TTM Avg
8.52%
3Y Avg
10.27%
5Y Avg
10.68%
Market Cap
$227.91M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.66M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$227.60M
Return on Invested Capital (ROIC)
-25.73%
TTM Avg
-40.62%
3Y Avg
-54.07%
5Y Avg
-54.31%
Market Cap
$235.97M
Return on Invested Capital (ROIC)
-6.63%
TTM Avg
16.95%
3Y Avg
21.30%
5Y Avg
28.21%
Market Cap
$236.82M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-28.34%
3Y Avg
-154.06%
5Y Avg
-154.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $231.77M | -701.55% | -1715.00% | -499.97% | -314.24% |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | -16.87% | -43.46% | -51.45% | -53.92% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -25.38% | -99.58% | -69.59% | -61.10% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 6.83% | 8.52% | 10.27% | 10.68% |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -7.08% | -12.89% | -21.42% | -39.95% |
| Biodesix, Inc. (BDSX)vs › | $227.60M | -25.73% | -40.62% | -54.07% | -54.31% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -6.63% | 16.95% | 21.30% | 28.21% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -28.14% | -28.34% | -154.06% | -154.06% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -59.90% | -142.39% | -118.24% | -103.50% |
ROIC
-701.6%
ROE
-695.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -701.55% |
| 2026-03-31 | -415.38% |
| 2025-12-31 | -5360.54% |
| 2025-09-30 | -872.94% |
| 2025-06-30 | -1224.59% |
| 2025-03-31 | -1237.77% |
| 2024-12-31 | -631.87% |
| 2024-09-30 | -216.02% |
| 2024-06-30 | -179.35% |
| 2024-03-31 | -187.94% |
| 2023-12-31 | -139.21% |
| 2023-09-30 | -106.03% |
| 2023-06-30 | -87.01% |
| 2023-03-31 | -70.97% |
| 2022-12-31 | -60.85% |
| 2022-09-30 | -48.82% |
| 2022-06-30 | -35.40% |
| 2022-03-31 | -30.68% |
| 2021-12-31 | -17.14% |
| 2021-09-30 | -11.85% |
| 2021-06-30 | -9.47% |
| 2021-03-31 | -7.46% |
| 2020-12-31 | -6.68% |
| 2020-09-30 | -19.81% |
